サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1784114

セルフテストの世界市場

Self-Testing

出版日
ページ情報
英文 198 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
セルフテストの世界市場
出版日: 2025年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

セルフテストの世界市場は2030年までに197億米ドルに達する見込み

2024年に123億米ドルと推定されるセルフテストの世界市場は、2024年から2030年にかけてCAGR 8.1％で成長し、2030年には197億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるキットは、CAGR 7.6%を記録し、分析期間終了時には114億米ドルに達すると予測されています。デバイス分野の成長率は、分析期間中CAGR 9.3％と推定されます。

米国市場は32億米ドル、中国はCAGR 7.9％で成長予測

米国のセルフテスト市場は、2024年に32億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 7.9%で推移し、2030年には32億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.4％と7.0％と予測されています。欧州では、ドイツがCAGR約6.6%で成長すると予測されています。

世界のセルフテスト市場- 主要動向と促進要因まとめ

なぜセルフテスト市場は人気を集めているのか？

セルフテスト市場は、消費者が健康管理のために、より便利で、プライベートで、迅速な診断ソリューションを求めていることから、大きな成長を遂げています。予防ヘルスケアに対する意識の高まりと、感染症、不妊症、コレステロール、ビタミン欠乏症などの家庭用検査キットの拡大が市場需要を牽引しています。COVID-19のパンデミックは、家庭での迅速抗原検査やPCR検査が広く利用されるようになり、セルフテストの採用を加速させました。診断技術の進歩により、セルフテストキットの精度と使いやすさが向上し、頻繁に病院を受診することなく健康状態を早期発見できるようになりました。さらに、遠隔医療サービスの台頭により、セルフテストはデジタルヘルスケアエコシステムにさらに統合され、遠隔地からの診察や治療提案を可能にしています。

どのような技術革新がセルフテストキットの効果を高めていますか？

マイクロ流体工学、バイオセンサー、人工知能（AI）を活用した診断における最近の技術革新は、セルフテストデバイスの精度と使いやすさを大幅に向上させています。ラボオンチップ技術により、コンパクトで費用対効果の高い検査ソリューションが実現し、少量の血液、唾液、尿サンプルから精密な生化学分析が可能になりました。Bluetoothとスマートフォン接続を備えたスマートセルフテストキットは、検査結果のリアルタイム追跡を可能にし、ユーザーはヘルスケアプロバイダーと即座にデータを共有することができます。AIベースの画像認識の統合は、ラテラルフロー検査の解釈をさらに強化し、ユーザーエラーのリスクを低減しています。さらに、呼気ベースのグルコースモニターや唾液ベースの遺伝子検査など、非侵襲的なセルフテスト手法の進歩が、在宅診断の範囲を拡大しています。

セルフテスト市場の成長を牽引するヘルスケア分野は？

セルフテストキットは、感染症スクリーニング、慢性疾患管理、個別化医療など、複数のヘルスケア分野で広く採用されるようになっています。糖尿病分野は、セルフテストデバイスの最大消費者の1つであり、継続的グルコースモニタリング（CGM）システムや血糖値検査ストリップは日々の疾病管理に不可欠です。女性の健康分野も成長を遂げており、不妊検査や妊娠検査キットがより進化して広く利用されるようになっています。家系やDNAによる健康リスク評価など、遺伝的なセルフテストの台頭は、家庭での診断に対する消費者の関心をさらに拡大させています。さらに、予防ヘルスケアへの注目の高まりは、コレステロール、心血管リスク評価、腸内マイクロバイオーム分析などのセルフテストソリューションへの需要を高めています。

セルフテスト市場の成長を促進している要因は？

セルフテスト市場の成長は、健康意識の高まり、予防ヘルスケアへのシフト、診断技術の向上など、いくつかの要因によってもたらされます。eコマースやDTC（Direct-to-Consumer）ヘルスケアブランドの拡大により、セルフテストキットは世界中の消費者にとってより身近なものとなっています。家庭用診断機器に対する政府の承認と償還政策の改善が、市場拡大をさらに後押ししています。遠隔医療とデジタルヘルスプラットフォームの統合も、セルフテストキットの需要を後押ししています。セルフテストキットは患者の遠隔モニタリングを可能にし、ヘルスケア施設の負担を軽減します。セルフテスト技術が進化し続けるにつれ、よりパーソナライズされた効率的なヘルスケアソリューションが提供され、市場の拡大が見込まれています。

セグメント

製品（キット、デバイス、ストリップ）;サンプル（血液、尿、便、その他）;用途（血圧検査、糖尿病・血糖値検査、コレステロール・中性脂肪検査、妊娠検査、性病検査、尿路感染症検査、がん検査、セリアック病検査、甲状腺検査、トランスアミナーゼ検査、貧血検査、アレルギー検査、その他）

調査対象企業の例

  • 2San
  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Assure Tech（Hangzhou）Co., Ltd.
  • Becton, Dickinson and Company（BD）
  • bioLytical Laboratories Inc.
  • Bionime Corporation
  • BioReference Laboratories, Inc.
  • Biozek Medical
  • Cardinal Health
  • Celltrion Inc.
  • Eurofins Scientific
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Geratherm Medical AG
  • Gold Standard Diagnostics
  • iHealth Labs Inc.
  • iuvo BioScience
  • Johnson & Johnson Services, Inc.
  • LetsGetChecked
  • Nectar Lifesciences Ltd.
  • OraSure Technologies, Inc.
  • PRIMA Lab SA
  • Quidel Corporation
  • Selfdiagnostics
  • Siemens Healthineers
  • True Diagnostics, Inc.
  • Wondfo

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32896

Global Self-Testing Market to Reach US$19.7 Billion by 2030

The global market for Self-Testing estimated at US$12.3 Billion in the year 2024, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$11.4 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 7.9% CAGR

The Self-Testing market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Self-Testing Market - Key Trends & Drivers Summarized

Why Is The Self-Testing Market Gaining Popularity?

The self-testing market is witnessing significant growth as consumers seek more convenient, private, and rapid diagnostic solutions for managing their health. The increasing awareness of preventive healthcare, along with the expansion of home-based testing kits for infectious diseases, fertility, cholesterol, and vitamin deficiencies, is driving market demand. The COVID-19 pandemic accelerated the adoption of self-testing, with at-home rapid antigen and PCR tests becoming widely available. With advancements in diagnostic technology, self-testing kits are becoming more accurate and user-friendly, enabling early detection of health conditions without the need for frequent hospital visits. Additionally, the rise of telehealth services is further integrating self-testing into digital healthcare ecosystems, allowing for remote consultation and treatment recommendations.

What Innovations Are Enhancing The Effectiveness Of Self-Testing Kits?

Recent innovations in microfluidics, biosensors, and artificial intelligence (AI)-powered diagnostics are significantly improving the accuracy and usability of self-testing devices. Lab-on-a-chip technology is enabling compact and cost-effective testing solutions, allowing for precise biochemical analysis from a small sample of blood, saliva, or urine. Smart self-testing kits equipped with Bluetooth and smartphone connectivity are allowing real-time tracking of test results, enabling users to share data with healthcare providers instantly. The integration of AI-based image recognition is further enhancing the interpretation of lateral flow tests, reducing the risk of user error. Additionally, advancements in non-invasive self-testing methods, such as breath-based glucose monitors and saliva-based genetic testing, are expanding the scope of home diagnostics.

Which Healthcare Segments Are Driving The Growth Of The Self-Testing Market?

Self-testing kits are becoming widely adopted across multiple healthcare sectors, including infectious disease screening, chronic disease management, and personalized medicine. The diabetes sector remains one of the largest consumers of self-testing devices, with continuous glucose monitoring (CGM) systems and blood sugar test strips being essential for daily disease management. The women’s health segment is also experiencing growth, with fertility and pregnancy test kits becoming more advanced and widely available. The rise of genetic self-testing, including ancestry and DNA health risk assessments, is further expanding consumer interest in at-home diagnostics. Additionally, the growing focus on preventive healthcare is increasing demand for self-testing solutions for cholesterol, cardiovascular risk assessment, and gut microbiome analysis.

What Factors Are Fueling The Growth Of The Self-Testing Market?

The growth of the self-testing market is driven by several factors, including increased health awareness, the shift toward preventive healthcare, and improvements in diagnostic technology. The expansion of e-commerce and direct-to-consumer (DTC) healthcare brands is making self-testing kits more accessible to consumers worldwide. Government approvals for at-home diagnostic devices, along with improved reimbursement policies, are further supporting market expansion. The integration of telemedicine and digital health platforms is also driving demand for self-testing kits, as they enable remote patient monitoring and reduce the burden on healthcare facilities. As self-testing technology continues to evolve, the market is expected to expand, offering more personalized and efficient healthcare solutions.

SCOPE OF STUDY:

The report analyzes the Self-Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Devices, Strips); Sample (Blood, Urine, Stool, Others); Application (Blood Pressure Test, Diabetes & Glucose Tests, Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • 2San
  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Assure Tech (Hangzhou) Co., Ltd.
  • Becton, Dickinson and Company (BD)
  • bioLytical Laboratories Inc.
  • Bionime Corporation
  • BioReference Laboratories, Inc.
  • Biozek Medical
  • Cardinal Health
  • Celltrion Inc.
  • Eurofins Scientific
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Geratherm Medical AG
  • Gold Standard Diagnostics
  • iHealth Labs Inc.
  • iuvo BioScience
  • Johnson & Johnson Services, Inc.
  • LetsGetChecked
  • Nectar Lifesciences Ltd.
  • OraSure Technologies, Inc.
  • PRIMA Lab SA
  • Quidel Corporation
  • Selfdiagnostics
  • Siemens Healthineers
  • True Diagnostics, Inc.
  • Wondfo

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Self-Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Convenient and At-Home Health Solutions Drives Growth in Self-Testing Products
    • The Rise of Chronic Disease Management and Preventative Healthcare Expands Market Opportunity for Self-Testing Solutions
    • Surge in Consumer Awareness of Health and Wellness Drives Adoption of Self-Testing Kits for Home Use
    • Technological Advancements in Diagnostics and Testing Devices Propel Market Growth for Self-Testing Products
    • Growing Preference for Privacy and Confidentiality in Health Management Strengthens the Demand for Self-Testing Solutions
    • The Expansion of Remote Healthcare and Telemedicine Services Creates New Opportunities for Self-Testing Products
    • Increasing Regulatory Approvals and Standards for Self-Testing Devices Accelerates Consumer Confidence and Market Growth
    • The Growth of the Wellness and Fitness Sector Strengthens the Adoption of Self-Testing for Health Metrics
    • Rising Healthcare Costs Drive Demand for Affordable, At-Home Testing Solutions for Chronic Conditions
    • Increasing Investment in Digital Health and Mobile Health Apps Expands the Role of Self-Testing in Remote Monitoring
    • Consumer Demand for Real-Time, Actionable Health Data Drives the Growth of Self-Testing Kits in Multiple Market Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Self-Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cholesterol & Triglycerides Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Cholesterol & Triglycerides Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Pregnancy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Pregnancy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for STD Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for STD Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinary Tract Infection Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Urinary Tract Infection Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cancer Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cancer Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Celiac disease Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Celiac disease Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Thyroid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Thyroid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Transaminase Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Transaminase Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Anemia Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Anemia Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Allergy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Allergy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Pressure Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Blood Pressure Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Diabetes & Glucose Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Diabetes & Glucose Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World 6-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Stool by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World 6-Year Perspective for Stool by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 43: World 6-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: USA 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: USA 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Canada 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • JAPAN
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • CHINA
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • EUROPE
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • FRANCE
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • GERMANY
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • UNITED KINGDOM
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Asia-Pacific 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 112: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of World 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 114: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of World 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030

IV. COMPETITION